Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
Chemical Biology & Drug Design · 2026
DOI: 10.1111/cbdd.70285 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2026. Written by Gözde Sayar and 5 co-authors. Institution: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey. Major MEDLINE topics: Glycogen Synthase Kinase 3 beta, Cholinesterase Inhibitors, Acetylcholinesterase, Benzimidazoles. Cited 3 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ege University Research Foundation.
Topics: Demenz
Abstract (original language)
A series of benzimidazoles and its analogs (benzoxazoles and benzothiazoles) bearing a benzohydrazide‐hydrazones moiety at the 2‐position were designed and synthesized as potential acetylcholinesterase (AChE) inhibitors. Cholinesterase (ChE) inhibitory activity results showed that all compounds displayed good inhibition of AChE, whereas only some of the compounds were active against BChE. Among the title compounds, it was found that all benzimidazole series were selective towards AChE. Kinetic analysis and molecular modeling studies were conducted on the most active compounds, namely 1j for AChE and 3g for BChE inhibition. The kinetic results showed that the tested compounds exhibited a mixed‐type inhibition mechanism on both enzymes. In cell culture studies, all compounds were evaluated for their neuroprotective effects against hydrogen peroxide (H 2 O 2 )‐induced oxidative stress in the SH‐SY5Y human neuroblastoma cell line. Several compounds demonstrated more than 30% neuroprotection at a low concentration (1 μM) in the presence of H 2 O 2 . Selected compounds, chosen based on their EC 50 values, were further examined for their effects on glycogen synthase kinase‐3 beta (GSK3β), an enzyme whose activity has been reported to be increased in the brains of patients with Alzheimer's disease (AD). The inhibition of GSK3β was assessed by measuring phosphorylated GSK3β (pGSK3β, Ser9) protein expression via Western Blot analysis under oxidative stress conditions. Among the tested compounds, 1l , 2b , 2j , and 3l significantly increased pGSK3β (Ser9) protein levels compared to cells treated with tideglusib, a known GSK3β inhibitor.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey.
- Department of Physiology, School of Medicine, Katip Celebi University, Izmir, Turkey.
- Department of Biochemistry, Faculty of Pharmacy, Ege University, Izmir, Turkey.
ORCID profiles: Sulunay Parlar, Mumin Alper Erdoğan, Vildan Alptuzun
Funding
- Ege University Research Foundation
Cite
APA
Sayar, G., Parlar, S., Tarikogullari, A. H., Erdoğan, M. A., Armagan, G., & Alptuzun, V. (2026). Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70285
Vancouver
Sayar G, Parlar S, Tarikogullari AH, Erdoğan MA, Armagan G, Alptuzun V. Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70285
BibTeX
@article{Sayar2026,
author = {Sayar, Gözde and Parlar, Sulunay and Tarikogullari, Ayse Hande and Erdoğan, Mumin Alper and Armagan, Guliz and Alptuzun, Vildan},
title = {Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease},
journal = {Chemical Biology & Drug Design},
year = {2026},
doi = {10.1111/cbdd.70285}
}
EUVIMED